HVAC and Active Air Purification specialist, Better Indoors, has been chosen by NHS East of England Collaborative Procurement under a Framework Supply Agreement.
Encompassing 22 NHS Trusts, the East of England NHS Collaborative Procurement process called for suppliers of equipment and services to aid the provision of Infection Control systems.
Headquartered in Surrey, Better Indoors, is the sole UK distributor of RGF Environmental Group, manufacturers of innovative active air purification technology that instantly eliminates harmful viruses and bacteria, including SARS-CoV-2 at the point of transmission.
Using no chemicals or harmful substances and requiring virtually no energy, the active air purification technology works by replicating Earth’s natural air cleaning processes indoors. It does this by producing and maintaining minute equilibrium concentrations of hydroperoxide molecules throughout the indoor air space. When these active molecules come into contact with microbials, they break them down and destroy them and then revert to harmless water vapour and oxygen. The technology produces 1 quadrillion hydroperoxide molecules every second, quickly killing any airborne virus or bacteria, including COVID-19.
Unlike products that require areas to be evacuated, active air purification technology is completely safe for people to work and live around and most importantly it provides continuous 24/7 protection without disrupting productivity or negatively affecting energy efficiency – one of the consequences of increased ventilation air changes.
Andrew Hobbs, Managing Director of Better Indoors, confirmed: “This is a huge honour for us and a major endorsement of RGF’s unique PHI and REME technologies. The ability to destroy viruses and microbials instantly at the point of transmission is what differentiates this technology which has helped other healthcare providers and systems elsewhere in the world reduce HAIs. Not only does it offer best possible indoor protections against viral emissions but it is not reliant on ventilation air change increases and so does not negatively impact energy efficiency. We look forward to working with the NHS to help make their facilities as safe as possible for staff, patients and all other visitors whilst maintaining their carbon footprint.”
Originally invented in the late 1990s, RGF’s PHI and REME active air purification technologies have been thoroughly verified for safety and efficacy by nationally accredited independent labs and testing bodies in the US and by other Governments. Experiments include the “sneeze test“ which proved the 3 foot instant elimination zone and 99.9%+ inactivation of a wide range of highly infectious viruses and bacteria including COVID-19, SARS, H1N1 or ‘Swine Flu’, Norovirus, MRSA, Bird Flu just to name a few.